Analysis of Exposure to Foreign Exchange Risk for U.S. Pharmaceutical Industry
Available Online October 2017.
- https://doi.org/10.2991/isbcd-17.2017.45How to use a DOI?
- Pharmaceutical industry; foreign operations; exposure to foreign exchange risk; risk management
- Multinational companies with a large proportion of foreign operations face one same problem which is foreign exchange risk. As for the world's largest economy, the United States has various kinds of industries that have global business and trade with currencies of different countries. American pharmaceutical industry is a very typical one, and I choose five sample firms (Merck, AbbVie, Pfizer, Bristol Myers and GSK) with comparably large size, healthy financial status and a lot of international business to analyze the exposure to foreign exchange risk and discuss the management of the risk and finally come up with my own recommendations.
- Open Access
- This is an open access article distributed under the CC BY-NC license.
Cite this article
TY - CONF AU - Shuting Niu PY - 2017/10 DA - 2017/10 TI - Analysis of Exposure to Foreign Exchange Risk for U.S. Pharmaceutical Industry BT - 2nd International Symposium on Business Corporation and Development in South-East and South Asia under B&R Initiative (ISBCD 2017) PB - Atlantis Press SP - 220 EP - 225 SN - 2352-5428 UR - https://doi.org/10.2991/isbcd-17.2017.45 DO - https://doi.org/10.2991/isbcd-17.2017.45 ID - Niu2017/10 ER -